NewsSun Pharma Announces US FDA Filing Acceptance of Biologics License Application (BLA) For Tildrakizumab
Tildrakizumab is being evaluated for treatment of moderate-to-severe plaque psoriasis Sun Pharmaceutical Industries Ltd (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE:...
